CTAC Patient Input Webinar: MK2 (Elbasvir/Grazoprevir)

Event Information

Share this event

Date and Time

Event description

Description

Please join CTAC Policy Researcher Adam Cook for an informative webinar detailing an exciting new HCV treatment, MK2 (Grazoprevir/Elbasvir). Currently undergoing review by the Common Drug Review, this treatment is intended to treat chronic HCV, genotypes 1 and 4.

Presenter Bio

Adam Cook is CTAC’s Policy Researcher specializing in HCV, regulatory affairs, and treatment development.

Date and Time

Save This Event

Event Saved